Colorado board won’t put a price cap on a massively expensive cystic fibrosis drug
Colorado board won’t put a price cap on a massively expensive cystic fibrosis drug
coloradosun.com Colorado board won’t cap price of cystic fibrosis drug that costs average of $234,439 per patient per year
The Colorado Prescription Drug Advisory Board declined to set a price cap on the massively expensive cystic fibrosis drug Trikafta
You're viewing a single thread.
6
comments
I would like to know if the creation of this drug was tax payer funded at any point. How much it costs to produce. How much the markup is. While I don't think the government should set prices in the free market I believe that fining companies for massive hikes over the initial cost of production not including the initial cost of research and creation. Also any drug that had tax payer money go into its creation should only be marked up a certain percent above production costs.
6
comments